Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Coherus Oncology, Inc. CHRS

Full chart Compare
Set alert

Price alert · CHRS

All alert types
0.85 USD +0.05 (+5.98%)

Nov 4, 2026, 3:42 PM EST

0.8117 Day range 0.8866
0.746 52-week range 2.62
YTD
-39.87%
1 year
-44.92%

Financial health

Altman Z-Score

-11.98 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E -1.0×
FY 2016: -9.3×FY 2017: -2.0×FY 2018: -2.8×FY 2019: 14.0×FY 2020: 9.4×FY 2021: -4.2×FY 2022: -2.1×FY 2023: -1.3×FY 2024: 5.5×FY 2025: -1.0×
FY 2016 5y median -1.3× FY 2025
P/S 4.1×
FY 2016: 6.2×FY 2017: 300×FY 2018: 378×FY 2019: 3.5×FY 2020: 2.6×FY 2021: 3.7×FY 2022: 2.9×FY 2023: 1.2×FY 2024: 0.6×FY 2025: 4.1×
FY 2016 5y median 2.9× FY 2025
P/B 2.8×
FY 2016: 61.0×FY 2017: 15.3×FY 2018: -15.2×FY 2019: 11.9×FY 2020: 4.4×FY 2021: 12.3×FY 2022: -4.5×FY 2023: -1.6×FY 2024: -1.2×FY 2025: 2.8×
FY 2016 5y median -1.2× FY 2025
P/FCF -1.2×
FY 2016: -4.6×FY 2017: -2.3×FY 2018: -3.7×FY 2019: 81.2×FY 2020: 8.4×FY 2021: -31.1×FY 2022: -2.5×FY 2023: -1.8×FY 2024: -7.7×FY 2025: -1.2×
FY 2016 5y median -2.5× FY 2025
EV/EBITDA -0.7×
FY 2016: -9.9×FY 2017: -2.0×FY 2018: -3.0×FY 2019: 11.4×FY 2020: 7.0×FY 2021: -4.6×FY 2022: -4.0×FY 2023: -3.6×FY 2024: 5.0×FY 2025: -0.7×
FY 2016 5y median -3.6× FY 2025
EV/Sales 2.9×
FY 2016: 6.1×FY 2017: 284×FY 2018: 398×FY 2019: 3.6×FY 2020: 2.3×FY 2021: 3.7×FY 2022: 4.9×FY 2023: 2.7×FY 2024: 1.1×FY 2025: 2.9×
FY 2016 5y median 2.9× FY 2025
FCF Yield -81.0%
FY 2016: -22.0%FY 2017: -43.8%FY 2018: -27.2%FY 2019: 1.2%FY 2020: 11.8%FY 2021: -3.2%FY 2022: -39.5%FY 2023: -55.9%FY 2024: -12.9%FY 2025: -81.0%
FY 2016 5y median -39.5% FY 2025

Profitability

Gross Margin 57.9%
FY 2016: -33.8%FY 2017: -10216.9%FY 2018: -107.9%FY 2019: 95.2%FY 2020: 92.1%FY 2021: 82.4%FY 2022: 66.8%FY 2023: 38.2%FY 2024: 56.0%FY 2025: 57.9%
FY 2016 5y median 57.9% FY 2025
Operating Margin -425.7%
FY 2016: -61.0%FY 2017: -14918.8%FY 2018: -13137.3%FY 2019: 30.3%FY 2020: 32.9%FY 2021: -80.8%FY 2022: -121.7%FY 2023: -79.0%FY 2024: -41.8%FY 2025: -425.7%
FY 2016 5y median -80.8% FY 2025
Net Margin -403.8%
FY 2016: -67.0%FY 2017: -15306.6%FY 2018: -13453.7%FY 2019: 25.2%FY 2020: 27.8%FY 2021: -87.9%FY 2022: -138.2%FY 2023: -92.5%FY 2024: 10.7%FY 2025: -403.8%
FY 2016 5y median -92.5% FY 2025
ROE -279.1%
FY 2016: -657.9%FY 2017: -780.0%FY 2018: 542.5%FY 2019: 85.4%FY 2020: 47.1%FY 2021: -293.8%FY 2022: 212.3%FY 2023: 123.0%FY 2024: -21.6%FY 2025: -279.1%
FY 2016 5y median -21.6% FY 2025
ROIC -151.8%
FY 2016: -94.9%FY 2017: -173.0%FY 2018: -308.8%FY 2019: 35.5%FY 2020: 21.8%FY 2021: -51.0%FY 2022: -74.1%FY 2023: -67.6%FY 2024: -66.8%FY 2025: -151.8%
FY 2016 5y median -67.6% FY 2025
ROA -65.9%
FY 2016: -71.3%FY 2017: -146.5%FY 2018: -210.5%FY 2019: 22.0%FY 2020: 15.7%FY 2021: -42.3%FY 2022: -60.7%FY 2023: -37.8%FY 2024: 6.4%FY 2025: -65.9%
FY 2016 5y median -42.3% FY 2025

Growth (YoY)

Revenue -84.2%
FY 2016: 532.8%FY 2017: -99.2%FY 2018: 0.0%FY 2019: 22783.7%FY 2020: 33.6%FY 2021: -31.4%FY 2022: -35.4%FY 2023: 21.9%FY 2024: 3.8%FY 2025: -84.2%
FY 2016 FY 2025
Operating Income -60.8%
FY 2016: 47.1%FY 2017: -100.2%FY 2018: 11.9%FY 2019: 152.7%FY 2020: 45.1%FY 2021: -268.8%FY 2022: 2.6%FY 2023: 20.9%FY 2024: 45.0%FY 2025: -60.8%
FY 2016 FY 2025
EPS (diluted) -680.0%
FY 2016: 49.4%FY 2017: -47.4%FY 2018: 28.1%FY 2019: 138.2%FY 2020: 31.7%FY 2021: -335.2%FY 2022: 1.3%FY 2023: 32.7%FY 2024: 109.9%FY 2025: -680.0%
FY 2016 FY 2025
Free Cash Flow -577.7%
FY 2016: -126.9%FY 2017: 20.9%FY 2018: 21.9%FY 2019: 109.7%FY 2020: 850.4%FY 2021: -126.4%FY 2022: -528.0%FY 2023: 28.0%FY 2024: 88.3%FY 2025: -577.7%
FY 2016 FY 2025

Financial Health

Current Ratio 1.5×
FY 2016: 2.2×FY 2017: 4.5×FY 2018: 2.2×FY 2019: 3.0×FY 2020: 5.3×FY 2021: 3.6×FY 2022: 2.7×FY 2023: 1.4×FY 2024: 1.2×FY 2025: 1.5×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.4×
FY 2016: 2.3×FY 2017: 4.5×FY 2018: 2.1×FY 2019: 2.9×FY 2020: 5.0×FY 2021: 3.4×FY 2022: 2.5×FY 2023: 1.2×FY 2024: 1.0×FY 2025: 1.4×
FY 2016 5y median 1.4× FY 2025
Debt / Equity 0.7×
FY 2016: 5.2×FY 2017: 3.3×FY 2018: -2.7×FY 2019: 1.8×FY 2020: 1.5×FY 2021: 4.3×FY 2022: -3.5×FY 2023: -2.5×FY 2024: -2.0×FY 2025: 0.7×
FY 2016 5y median -2.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 0.2×FY 2017: 0.1×FY 2018: -0.2×FY 2019: 0.1×FY 2020: -0.8×FY 2021: -0.0×FY 2022: -1.6×FY 2023: -1.9×FY 2024: 2.4×FY 2025: 0.3×
FY 2016 5y median -0.0× FY 2025
Interest Coverage -19.9×
FY 2016: -14.5×FY 2017: -24.3×FY 2018: -21.1×FY 2019: 6.1×FY 2020: 7.4×FY 2021: -11.5×FY 2022: -7.9×FY 2023: -5.0×FY 2024: -4.1×FY 2025: -19.9×
FY 2016 5y median -7.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31